Valproate for the Treatment of Residual Amblyopia

Clinical trial NCT07226141 · RECRUITING

Trial details

NCT number: NCT07226141
Sponsor: Boston Children's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amblyopia Amblyopia Unilateral Amblyopia, Anisometropic Amblyopia Strabismic

Start date: 2026-07-01
Primary completion: 2027-09-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.